Chronic lymphocytic leukemia: anti-CD20 therapeutic antibodies and BCR kinase inhibitors overcome leukemic cell resistance to venetoclax (ABT-199).

ELIAS ESTEBAN ENRIQUE; ALMEJUN MARIA BELÉN; BORGE MERCEDES; COLADO ANA; PODAZA, ENRIQUE; RISNIK, DENISE; FERNANDEZ GRECCO HORACIO; CLAVIJO M; CASALE; GARATE, GONZALO MARTÍN; BEZARES RAIMUNDO FERNANDO; GIORDANO, MIRTA; GAMBERALE, ROMINA

Congreso; Reunión Conjunta de Sociedades de Biociencias 2017; 2017

Chroniclymphocytic leukemia: anti-CD20 therapeutic antibodies and BCR kinaseinhibitors overcome leukemic cell resistance to venetoclax (ABT-199). EEElías, MB Almejún, M Borge, A Colado, E Podaza, D Risnik, HF Grecco, M Clavijo,C Casali, G Garate, RF Bezares, M Giordano and R Gamberale. Abstract 1051. ReuniónConjunta de Sociedades de Biociencias 2017, Buenos Aires, Argentina, November2017. MEDICINA - Volumen 77- (Supl. I), 2017